China joins WHO vaccine initiative, aiming to provide innoculations worldwide
The COVAX alliance involves countries working together to develop a vaccine for the coronavirus.
China announced it is joining the World Health Organization's COVAX alliance initiative, in which countries are working together to develop a COVID-19 vaccine.
The alliance deadline was in September, however, China said it is now willing to become a part of initiative. China has several vaccines in the final stages of clinical trials.
"We are taking this concrete step to ensure equitable distribution of vaccines, especially to developing countries, and hope more capable countries will also join and support COVAX," Chinese ministry spokeswoman Hua Chunying said in a statement.
President Trump declined to be involved with the initiative, saying it is "influenced by the corrupt WHO and China."
COVAX plans to buy 2 billion doses of a vaccine by the end of 2021.
Chinese pharmaceutical company Sinovac recently stated it wants to provide its vaccine to the world, including the U.S. and countries in Europe. Regulations have prevented previous Chinese vaccines from being sold, however, joining COVAX may allow the Chinese to provide a vaccine worldwide.
News, Not Noise
- Health officials less confident in COVID vaccine efficacy with rise of Delta variant
- CDC justified new mask guidance based on vaccine study listed as failing peer review
- Black leaders cite wide gap between Washington solutions, what middle class black voters want
- Legal effort targets Minnesota government promotion of critical race theory, Black Lives Matter
- MyPillow CEO Mike Lindell says he's pulling ads from Fox News following disagreement